Loading…
Fierce JPM Week - In Person Agenda
Attending this event?

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Tuesday, January 11
 

7:30am PST

Registration & Networking Breakfast
Tuesday January 11, 2022 7:30am - 8:15am PST
Live In-Person

8:15am PST

New paths to trial diversity
To get drug development done through COVID-19 lockdowns and social distancing, trial sponsors turned to new technology—from data management to patient monitoring—and decentralized procedures. Those same methods could potentially help biopharma bring real diversity to future clinical trials. But hurdles to these patient-centric trials still remain. How can drugmakers clear those obstacles and tap technology to make their trials look like the patient populations who’ll use the treatments being tested?  

Moderators
avatar for Annalee Armstrong

Annalee Armstrong

Senior Editor, Fierce Biotech
Annalee Armstrong is a senior editor for Fierce Biotech. Prior to joining Fierce in April 2021, Annalee was an associate editor for S&P Global Market Intelligence’s healthcare news team. Before that, she was the EPA reporter covering climate and energy policy on the Hill in Washington... Read More →

Speakers
avatar for Keiki Oishi

Keiki Oishi

President and COO, CMIC Group
Ms. Oishi is the President and COO of CMIC HOLDINGS Co., Ltd., responsible for group-wide business execution.Ms. Oishi received her Master of Science degree from the University of Tokyo. She started her career at Nikkei McGraw-Hill, Inc. in Japan (now renamed Nikkei Business Publications... Read More →
avatar for Gregory Rotz

Gregory Rotz

Principal, PwC US
Greg Rotz is a Principal with PwC and leads the transformation consulting practice focused on Pharmaceuticals and Life Sciences (PLS). He brings nearly 25 years of experience shaping and serving the C-suite agenda for his clients.In his sector leadership role, Greg’s focus is to... Read More →
avatar for Craig Tendler, M.D.

Craig Tendler, M.D.

Global Head, Late-Stage Clinical Development, Diagnostics & Medical Affairs, Hematology & Oncology, Janssen
Craig Tendler, M.D. is Vice President, Oncology Clinical Development and Global Medical Affairs at Janssen Research & Development, LLC. In this position, he is responsible for creating robust development plans and data generation activities for all therapies in the oncology portfolio... Read More →


Tuesday January 11, 2022 8:15am - 9:30am PST
Live In-Person

9:30am PST

Coffee & Networking Break
Tuesday January 11, 2022 9:30am - 10:00am PST
Live In-Person

10:00am PST

CEO Presentation
Tuesday January 11, 2022 10:00am - 10:15am PST
Live In-Person

10:15am PST

Why the foundations of Cellular Research Matter: High quality Cellular Data Holds the Key to Post COVID development of gene- and cell-therapies.
 This is the era of big data. We are witnessing the generation of vast amounts of data from cells using state-of-the-art analyzers, sequencers and other high throughput research devices. These data are resolved using sophisticated analytical tools powered by AI. These technological advances are expected to bring forth better insights and understanding of target diseases, as well as guide strategies for development of therapies. In spite of the staggering advances in technology, the most critical and often overlooked step in these studies is the quality of cell samples and associated cell sample preparations. This is often underlined by the quality of data in spite of the sophisticated analytical tools as best described by the adage- “garbage in- garbage out” The irony is reflected in the current usage of cell prep protocols and tools dating back to the 1970s. Curiox is poised to bring the much needed global revolution to advance cell preparation through standardization and automation; to unlock the power of the latest technology and their impact on the development of cell and gene therapies.

Speakers
avatar for Dr. Namyong Kim

Dr. Namyong Kim

CEO, Curiox
To inspire change, one must see past tomorrow. Curiox co-founder Dr. Namyong Kim executes this as the CEO and lead inventor. At Curiox since 2008, he has grown a spin-off project from A*STAR in Singapore to a company headquartered in Seoul, Korea with operations worldwide. Under his... Read More →


Tuesday January 11, 2022 10:15am - 10:30am PST
Live In-Person

10:30am PST

Executive Presentation: Shirin Hasan, Associate Vice President, Head of Global Clinical Affairs, Agilent Technologies
Speakers
avatar for Shirin Hasan

Shirin Hasan

Associate Vice President, Head of Global Clinical Affairs, Agilent Technologies
Shirin Hasan is a seasoned executive in the healthcare industry, with proven leadership and in-depth experience in bringing a concept to market to improve the quality of patient lives. Shirin's career spanning over 25 years in medical diagnostics, therapeutics and biotech, has included... Read More →


Tuesday January 11, 2022 10:30am - 10:45am PST
Live In-Person

10:45am PST

CEO Presentation
Tuesday January 11, 2022 10:45am - 11:00am PST
Live In-Person

11:00am PST

Panel: Digital-first launches — The new post-COVID landscape
As a result of the pandemic, many pharma and biotech companies could not launch products in the same manner as they had done previously with face-to-face interactions with HCPS.  Companies needed to adapt and launch their products completely digitally which created unique challenges but also new opportunities for the future.  We will look at what worked, what didn’t and discuss strategies for these types of launches going forward.

Tuesday January 11, 2022 11:00am - 12:00pm PST
Live In-Person

12:00pm PST

Networking Lunch Sponsored by Curiox
Use this time to connect with colleagues, schedule meetings using our partnering app, or work freely in your designated work space on-site.  Lunch and refreshments will be provided.

Tuesday January 11, 2022 12:00pm - 1:30pm PST
Live In-Person

1:30pm PST

The Power of Data to Measure, and Ultimately Address, Care Disparities
Speakers
avatar for Web Sun

Web Sun

Co-Founder & President, Komodo Health
Web Sun is co-founder and President at Komodo Health. He oversees operations, including business development, sales and marketing, and people. Prior to founding Komodo Health, Web was a managing director at Zephyr Health, a leading life sciences data and insights solution provider... Read More →


Tuesday January 11, 2022 1:30pm - 1:45pm PST
Live In-Person

1:45pm PST

CEO Presentation: David A. Ricks, Chairman and CEO, Eli Lilly and Company
Speakers
avatar for David A. Ricks

David A. Ricks

Chairman and CEO, Eli Lilly and Company
Dave Ricks is chairman and chief executive officer of Eli Lilly and Company. He became CEO in January 2017 and was elected chairman of the company’s board effective June 2017.A Lilly veteran for more than 20 years, Dave served as president of Lilly Bio Medicines from 2012 to 2016... Read More →


Tuesday January 11, 2022 1:45pm - 2:00pm PST
Live In-Person

2:00pm PST

CEO Presentation
Tuesday January 11, 2022 2:00pm - 2:15pm PST
Live In-Person

2:15pm PST

CEO Presentation: Mark Moore, CEO, GemPharmatech
Speakers
avatar for Mark Moore

Mark Moore

CEO, GemPharmatech


Tuesday January 11, 2022 2:15pm - 2:30pm PST
Live In-Person

2:30pm PST

Coffee & Networking Break
Tuesday January 11, 2022 2:30pm - 2:45pm PST
Live In-Person

2:45pm PST

Collaboration, 2022 style
In 2020, the pandemic spurred drugmakers to band together to find solutions. Vaccine rivals teamed up on development, a consortium of players pooled resources for plasma research, Big Pharma teamed to scale up manufacturing and more. Executives across the industry talked about extending that cooperative spirit beyond the pandemic. What’s the state of collaboration in biopharma now? We’ll explore the latest cooperative efforts tackling the pandemic and other common problems the industry wants to solve. 

Moderators
avatar for Eric Sagonowsky

Eric Sagonowsky

Senior Editor, Fierce Pharma
Eric Sagonowsky is an editor with the FierceMarkets Life Sciences team. Before joining Fierce in November 2014, Eric worked as a news reporter for the Manistee News Advocate in Manistee, Mich., covering government and crime issues. Eric graduated from Ohio University's E.W. Scripps... Read More →

Speakers
avatar for ​Alban De-La-Sabliere

​Alban De-La-Sabliere

Head of Sanofi Partnering, Sanofi
​Alban De-La-Sabliere is Head of Sanofi Partnering, in charge of Sanofi Ventures, Business Development & Licensing, Alliance Management and Competitive Intelligence. The Sanofi Partnering team is a major contributor in making Sanofi’s pipeline one of the best and most exciting... Read More →
avatar for Marianne De Backer, MSc, PhD, MBA

Marianne De Backer, MSc, PhD, MBA

Chief Business Officer, EVP, Head of Pharmaceuticals Strategy, Business Development & Licensing & Open Innovation and Member of Executive Committee, Bayer Pharmaceuticals
Marianne De Backer is a strategist, scientist, business leader, deal maker, and corporate investor in the healthcare industry. She has more than two decades of experience, and a network that spans across pharmaceutical, biotech, tech, academia, VC, NGO, and government partners worldwide... Read More →
avatar for Angus Grant

Angus Grant

Chief Business Officer, BeiGene
Angus Grant, Ph.D. joined BeiGene in June 2020 as Chief Business Executive, bringing in more than 25 years of experience across multiple key functions in the biotech industry, including business development, alliance management, research and development, and regulatory affairs . In... Read More →
avatar for Cristin Hubbard

Cristin Hubbard

Global Head of Diagnostics Partnering, Roche
Cristin Hubbard is responsible for bringing external innovation into the Roche Diagnostics Group. In her role as Global Head of Diagnostics Partnering, Cristin is a member of the Diagnostics Leadership Team based at Roche’s Headquarters in Basel.  Having grown up in California... Read More →
avatar for Martin Meeson

Martin Meeson

CEO, FUJIFILM Diosynth Biotechnologies
Martin Meeson is a seasoned executive who brings extensive global experience to the Biotech and Pharmaceutical markets.Martin was named Chief Executive Officer on April 1st, 2020, after serving as Chief Operating Officer and President of our US FDB operations (North Carolina and Texas... Read More →


Tuesday January 11, 2022 2:45pm - 4:00pm PST
Live In-Person

4:00pm PST

Cocktail Reception Sponsored by FUJIFILM Diosynth Biotechnologies
Join us for cocktails and light refreshments to close out the day.  Thank you to FUJIFILM Diosynth Biotechnologies for sponsoring our reception.  

Tuesday January 11, 2022 4:00pm - 5:00pm PST
Live In-Person